Thu,27 October 2011
2 medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for 6 months, despite concerns about eye-related complication.
The advent of the medications sildenafil citrate (sold as Viagra), tadalafil (sold as Cialis) and verdenafil hydrochloride (sold as Levitra) has profoundly changed the treatment of erectile dysfunction, according to background information in the article. These medications are known as selective phodiesterase type 5 (PDE5) inhibitors because they treat erectile d
Thu,27 October 2011
Patients in the UK suffering from a rare life-threatening heart condition, pulmonary arterial hypertension (PAH), could soon be offered a new treatment.
Drug company Pfizer has launched Revatio for use in patients with this condition which produces abnormal pressure levels in the blood vessel that leads from the heart to the lungs.
Sufferers experience breathlessness, fainting, chest pains and tiredness. The condition affects about 100,000 people worldwide and is most commonly seen in women between the ages of 20 and 40.
Thu,27 October 2011
The launch of sildenafil (Viagra) had an adverse effect on the morale of men who found it did not work, according to new research. It also reveals that men are more distressed by erectile dysfunction than has generally been realised. Researchers interviewed a random sample of 40 men prescribed sildenafil who had attended a men's health clinic in the year before the study. The average age of respondents was 52 years.
Erectile dysfunction caused serious distress to all those men who experienced it, with marked effects on their self-esteem and wellbeing |
